Tweet
<img alt="" height="1" width="1" />
Data shows new Roche leukemia drug may improve on Rituxan
Reuters
By Bill Berkrot. Wed May 15, 2013 6:19pm EDT. (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as long as chemotherapy, according to ...
Roche Experimental Leukemia Drug Helps Shrink TumorsBloomberg
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal StudyXconomy
ASCO '13 Preview: Roche's Next-Gen Rituxan Steps UpTheStreet.com
FierceBiotech -Wall Street Journal (press release)
all 8 news articles »
More...